263 related articles for article (PubMed ID: 25400757)
1. B7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma.
Fan M; Zhuang Q; Chen Y; Ding T; Yao H; Chen L; He X; Xu X
Int J Clin Exp Pathol; 2014; 7(10):6768-75. PubMed ID: 25400757
[TBL] [Abstract][Full Text] [Related]
2. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
[TBL] [Abstract][Full Text] [Related]
3. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A
Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target.
Go H; Kim PJ; Jeon YK; Cho YM; Kim K; Park BH; Ku JY
Eur J Cancer; 2015 Sep; 51(14):1937-45. PubMed ID: 26238015
[TBL] [Abstract][Full Text] [Related]
5. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S
World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517
[TBL] [Abstract][Full Text] [Related]
7. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.
Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H
Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
[TBL] [Abstract][Full Text] [Related]
9. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
[TBL] [Abstract][Full Text] [Related]
10. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases.
Liang L; Jiang Y; Chen JS; Niu N; Piao J; Ning J; Zu Y; Zhang J; Liu J
Hum Pathol; 2016 Nov; 57():1-6. PubMed ID: 27349304
[TBL] [Abstract][Full Text] [Related]
11. Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder.
Xylinas E; Robinson BD; Kluth LA; Volkmer BG; Hautmann R; Küfer R; Zerbib M; Kwon E; Thompson RH; Boorjian SA; Shariat SF
Eur J Surg Oncol; 2014 Jan; 40(1):121-7. PubMed ID: 24140000
[TBL] [Abstract][Full Text] [Related]
12. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
[TBL] [Abstract][Full Text] [Related]
13. Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance.
Tang X; Xing J; Li W; Wu Z; Zhang K; Zheng J
J BUON; 2013; 18(1):211-9. PubMed ID: 23613408
[TBL] [Abstract][Full Text] [Related]
14. Association of B7-H4 gene polymorphisms in urothelial bladder cancer.
Özgöz A; Şamli M; Dinçel D; Şahin A; Ince Ü; Sağlican Y; Balci F; Şamli H
Turk J Med Sci; 2017 Apr; 47(2):443-446. PubMed ID: 28425229
[TBL] [Abstract][Full Text] [Related]
15. B7-H4 expression is associated with cancer progression and predicts patient survival in human thyroid cancer.
Zhu J; Chu BF; Yang YP; Zhang SL; Zhuang M; Lu WJ; Liu YB
Asian Pac J Cancer Prev; 2013; 14(5):3011-5. PubMed ID: 23803071
[TBL] [Abstract][Full Text] [Related]
16. Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival.
Luo JH; Xie D; Liu MZ; Chen W; Liu YD; Wu GQ; Kung HF; Zeng YX; Guan XY
Int J Cancer; 2008 Jun; 122(11):2554-61. PubMed ID: 18246597
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
18. Editorial comment on: Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
Kruck S; Sievert KD
Eur Urol; 2009 Nov; 56(5):845-6. PubMed ID: 18945542
[No Abstract] [Full Text] [Related]
19. Editorial comment on: Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
Montironi R; Scarpelli M; Lopez-Beltran A; Cheng L
Eur Urol; 2009 Nov; 56(5):846-7. PubMed ID: 18945536
[No Abstract] [Full Text] [Related]
20. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
